Cerity Partners LLC lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 9.9% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 17,589 shares of the exchange traded fund’s stock after acquiring an additional 1,590 shares during the period. Cerity Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $1,604,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in the company. Kohmann Bosshard Financial Services LLC bought a new position in SPDR S&P Biotech ETF during the fourth quarter worth $29,000. Golden State Wealth Management LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $29,000. Avior Wealth Management LLC grew its stake in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after buying an additional 307 shares during the last quarter. Lee Danner & Bass Inc. bought a new position in SPDR S&P Biotech ETF in the 4th quarter valued at about $38,000. Finally, Bank of Jackson Hole Trust acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $43,000.
SPDR S&P Biotech ETF Stock Down 1.8 %
Shares of NYSEARCA:XBI opened at $75.13 on Thursday. SPDR S&P Biotech ETF has a 12-month low of $66.66 and a 12-month high of $105.47. The business has a 50 day moving average of $84.31 and a 200-day moving average of $91.47. The stock has a market cap of $4.74 billion, a PE ratio of 11.47 and a beta of 1.00.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- What Are Earnings Reports?
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- Insider Buying Explained: What Investors Need to Know
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- Investing in Commodities: What Are They? How to Invest in Them
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.